OPERATING GRANTS COMPETITION


The Operating Grants Competition is the principal means by which the Cancer Research Society fulfills its mission to support fundamental, early translational and environment-cancer research on all types of cancer to contribute to the advancement of science aimed at preventing, detecting and treating this disease.

Our Operating Grants Competition takes place every year and is open to researchers across Canada.


Amount: $60,000 per year
Duration: 2 years
Start date: September 1



KEY DATES | 2017-2019 GRANTS


November 7, 2016
Letter of Intent instructions and form available online
*Submitting a Letter of Intent is mandatory for all applicants

December 5, 2016, 11:59 pm (EST)
Deadline for submitting the Letter of Intent

December 16, 2016
Results of the Letters of Intent are announced

December 16, 2016
Application instructions and form available online

February 16, 2017, 11:59 pm (EST)
Deadline for submitting full application*

April 17, 2017
Deadline for Publications Updates

August 2017
Results are announced following approval of the Cancer Research Society’s Board of Directors.

September 1, 2017
Payments to grantees begin

*Only those applicants who submitted a Letter of Intent may submit a complete application. Applicants will receive an e-mail with the PIN(s) assigned to their project(s) no later than December 16, 2016. If by January 4, 2017 you have not received the confirmation e-mail with your PIN(s), please contact us without delay at grants@src-crs.ca.



 
FORMS, REPORTS AND INSTRUCTIONS

» Financial Rules and Report Form
» Scientific Report
» 2017 Letter of Intent instructions

» 2017 Letter of Intent form
» 2017 Application instructions
» 2017 Application form *soon
» 2017 Disclaimer and Indemnity form



FREQUENTLY ASKED QUESTIONS (FAQs) - 2017 COMPETITION

ELIGIBILITY
Q : Who can submit an application?
Q : What types of research are eligible?
Q : I am a foreign citizen and my Canadian permanent residency application is in progress. Can I still apply for an operating grant?

LETTER OF INTENT
Q :
How should I name my letter of intent file?


APPLICATION
Q : What are the targeted funding opportunities in the 2017 Operating Grants Competition?
Q :
Is there a limit to the number of applications I can submit?
Q : Am I allowed to receive funding for an overlapping project from other agencies?
Q : May I submit the same application to other funding agencies?
Q : After submitting my application, may I update it with recent Awards/Publications?
Q : What is the best panel for my application?
Q : How will my application be evaluated? What criteria will be used?
Q : How will the scoring of my application be determined?
Q : My actual grant is about to finish. Can I submit an application for the renewal of my grant?
Q : Are changes in the title permitted if the grant is renewed?

CERTIFICATES
Q : What certificates are required for my research project?

REPORTS
Q : What is the scientific report?



ELIGIBILITY

Q : Who can submit an application?

  • All applicants and co-applicants must hold an academic appointment at a Canadian university or accredited institution.
  • All applicants must be Canadian citizens or permanent residents.
  • Candidates in postdoctoral training are not eligible.
  • Research associates are not eligible.
  • Staff scientists are not eligible.
There must be only one main applicant for the purposes of this award. This person will also administer any grant awarded. All other applicants are considered co-applicants.
↑ Back to top

Q : What types of research are eligible?
The Cancer Research Society Operating Grants award program is offered to research projects in basic and fundamental, early translational and environment-cancer research.

Applied, psychosocial or clinical research projects are not admissible to this program
↑ Back to top

Q : I am a foreign citizen and my Canadian permanent residency application is in progress. Can I still apply for an operating grant?
You may apply but you will have to provide the status of your permanent residency application when applying. You will have to send us the confirmation of permanent residency by the time the grant starts.
↑ Back to top


LETTER OF INTENT

Q : How should I name my letter of intent file?
The filename of your letter of intent must be structured as follows: Last name_First name_ Letter of Intent_OG 2017. For example, Smith_John_Letter of Intent_OG 2017.pdf. Please indicate this filename in the subject line of the e-mail you will send.

For applicants submitting more than one letter of intent, please differentiate between your forms by numbering them. For example: Smith_John_Letter of Intent _OG 2017_1
↑ Back to top


APPLICATION

Q : What are the targeted funding opportunities in the 2017 Operating Grants Competition?
The Cancer Research Society is pleased to offer targeted funding opportunities to the scientific community through our regular competition. These grants on specific types of cancer are in addition to the regular operating grants applicable to all types of cancer.

The funding of these targeted grants is made possible thanks to significant collaborations that the Cancer Research Society has developed over the last years with valuable partners.

***If you apply for a targeted grant award, you must check the designated box on the Letter of Intent and Application forms. You will be required to justify, on the Application form, how your project applies to the specific area(s) of research you selected.

Targeted funding opportunities:
Breast Cancer: Through partnerships with the Breast Cancer Society of Canada, the Cancer Research Society will be co-funding one additional operating grant on breast cancer.

Childhood Cancer: Through a partnership with C17 Council, a non-profit organization led by experts in pediatric oncology/hematology to encourage and develop collaborative research that will ultimately improve health outcomes and quality of life for children in Canada who are fighting cancer, the Cancer Research Society will be co-funding one additional operating grant. Applications are sought that fit within the shared scope of C17 and the Cancer Research Society—those that focus on discovery to translational research in children, with a clear potential for future application to novel therapeutic approaches, improved treatment efficacy or reduced immediate- to late-effects resulting from the biological consequences of cancer, anti-cancer treatment, or both. 

Environment-Cancer: Four operating grants supported through the Cancer Research Society’s Environment-Cancer FundTM in partnership with Read for the Cure are available. Grants in environment-cancer are dedicated to finding scientific evidence relating the risk of developing cancer to the impact of environmental factors, such as our lifestyle (eating habits, physical activity, etc.) and our working, leisure and living environments. Since 2006, the Environment-Cancer FundTM is funded in part by Read for the Cure, a non-profit volunteer organization, formed by passionate Canadian book lovers.

Malignant Mixed Müllerian Tumour: Through its partnership with the Ann Matyas Memorial Fund, the Cancer Research Society will be co-funding one operating grant on mixed Müllerian tumours.

Multiple Myeloma: Through a partnership with Myeloma Canada, the Cancer Research Society will be co-funding one additional operating grant on multiple myeloma. The research project must be directly related to myeloma and aligned with the objective of improving patient outcomes within two to three years. As such, priority will be given to the submission deemed to have the greatest probability of positively affecting clinical practice within the defined time frame. The focus will be on proposals that contribute to the advancement of clinical practice through translational research.

Non-Hodgkin Lymphoma: Through the support of the Daniel Primeau Research Fund, the Cancer Research Society will be co-funding one operating grant on indolent non-Hodgkin lymphoma.

Ovarian Cancer: Through a partnership with Ovarian Cancer Canada, the Cancer Research Society will be co-funding one operating grant on ovarian cancer.

Pancreatic Cancer: Through its partnership with the Charlotte Légaré Memorial Fund, the Cancer Research Society will be co-funding two operating grants on pancreatic cancer.
↑ Back to top


Q : Is there a limit to the number of applications I can submit?
The number of applications a researcher may submit as the main applicant is not limited. A researcher may also participate in other projects as a co-applicant.
↑ Back to top

Q : Am I allowed to receive funding for an overlapping project from other agencies?
Each project funded by the Society must be original. The Society will not award a grant overlapping fully or partially with a grant obtained from another funding agency for the support of a project.

Should an applicant choose to accept a grant from another funding agency for a fully or partially overlapping project, it is incumbent upon the applicant to inform the Cancer Research Society immediately of these circumstances.

Failure to comply with these rules will lead to the cancellation of an awarded grant. Where applicable, a grantee may be required to reimburse paid installments for a grant obtained which was not in compliance with the Society’s rules.
↑ Back to top

Q : May I submit the same application to other funding agencies?
The same application may be submitted to other funding agencies. However, in the case of a successful outcome in various competitions, you will be asked to choose which funding you accept.
↑ Back to top
 

Q : After submitting my application, may I update it with recent Awards/Publications?
Applicants may update their award notices and publication lists after submission of their full applications.

Publication updates must be provided via e-mail to grants@src-crs.ca no later than April 28, 2017.
↑ Back to top

Q : What is the best panel for my application?
All applications are reviewed by one of our peer-review committees made up of 14 to 17 Canadian and/or international scientists with expertise in the appropriate domains of cancer research. The applications are assessed based on the research area and topic and are categorized into one of the following four panels:
Panel A: Cell Signaling
Panel B: Pharmacogenetics/Cancer Immunology
Panel C: Tumour suppressor genes, oncogenes and DNA repair
Panel D: Tumour progression and metastasis
Panel E: Early translational research and epidemiology

To consult the different topics covered in each panel, please click here.

The Cancer Research Society will try to assign the application to the first panel choice selected by the researchers. However, we reserve the right to make the final decision regarding the assignment of the application to either one of the two selected panels. 
↑ Back to top

Q : How will my application be evaluated? What criteria will be used?
How will my application be evaluated? What criteria will be used?

Your application will be assessed based on the following criteria: 

  • originality of the research plan
  • ability of the investigators to conduct the research in their respective milieu;
  • significance of the project to cancer research;
  • strengths and weaknesses of the proposal;
  • budget relevance:
    • No monies are allowed for travel or equipment;
    • The budget must be appropriate to the proposed project.

↑ Back to top

Q : How will the scoring of my application be determined?
The expert panels conduct a critical and distinct analysis of each application, which is first reviewed and scored by two expert and impartial reviewers, to then be discussed and scored by the entire panel.

The overall scientific score of the research project is determined after a thorough discussion of the application by the entire evaluation committee and may differ from the initial scores attributed by the two reviewers providing written evaluation reports.

Cancer Research Society funding is allocated to projects with the highest scores and, where applicable, to projects that fulfill the requirements for grants on targeted cancer research topics as a result of partnerships with the Cancer Research Society.

To be considered for funding, a project must meet the Cancer Research Society’s assessment criterion of a minimum score of 7.5 out of 10. Due to the high quality of proposals received each year and lack of available funds, not all projects with this minimum scientific score are funded.

All applicants, regardless of their score, will receive an official letter notifying them of the outcome of their application. If an applicant refuses the offered funding, the Cancer Research Society will offer the grant to the next meritorious project on the list.

Cancer Research Society decisions are final.
↑ Back to top


Q : My actual grant is about to finish. Can I submit an application for the renewal of my grant?
Researchers who currently have a grant with the Cancer Research Society may submit an application to renew their current project.

A project that has already been the subject of an application for renewal, or a project for which the financial support granted by the Cancer Research Society is already completed cannot be considered for a renewal application.

Submitting a Letter of Intent is also mandatory for operating grant renewals.

Conditional upon approval, a renewal may be granted for an additional two years.

***Researchers awarded a grant renewal must still submit the final Financial and Scientific Reports for the original project.

Grant renewals are not guaranteed. Applicants should ensure that their internal arrangements allow for possible non-renewal of the grant.

Applicants whose grants have not been renewed can subsequently apply for a new operating grant in the next competition.
↑ Back to top

Q : Are changes in the title permitted if the grant is renewed?
Yes, you may change the title. However, it should be made clear for the reviewers that this is the continuity of a project funded by the Society.
↑ Back to top



CERTIFICATES

Q :
What certificates are required for my research project?
Biosafety Certificate:
All projects involving work with potentially biohazardous materials require a biosafety certificate. These include 1) cell lines of all origins, 2) living animals, 3) human samples and 4) potentially pathogenic nucleic acids. We expect all researchers working in a wet lab to provide this certificate. Please contact your institution’s biosafety department for details.

Animal Care Certificate: All projects involving the use of living animals require an animal care certificate.

Human Ethics/Human Stem Cells: Every project involving human or human stem cells requires the approval of the Research Ethics Board of the principal investigator’s institution.

Important   New requirement for the use of Human Biospecimens
The Cancer Research Society is committed to ensuring that high quality biospecimens are used in the research that it funds. For this reason, the Cancer Research Society requires that:
1. all retrospective (old) biospecimens used in the Cancer Research Society‐funded research have come from Canadian Tissue Repository Network (CTRNet) or Clinical Laboratory Improvement Amendments Act (CLIA) ‐certified or -registered bio‐repositories.
2. all prospective (new) biospecimens to be used in the Cancer Research Society‐funded research will be added to registered or certified bio-repositories in accordance with the standards set by the CTRNet and/or the CLIA of the United States.

Description of the CTRNet registration and certification program for biobanks can be found here.

Required certificates may follow the application’s approval for funding, but must all be received before the payment of the first installment.
  
The award will be revoked if the grantee and co-applicants fail to comply with these rules.
↑ Back to top



REPORTS

Q : What is the scientific report?

The deadline for submitting a Scientific Report is November 30, at the end of the project.

For all terminating projects, regardless of whether or not a renewal of the project has been accepted for funding by the Cancer Research Society, a final scientific report is required.

If you were awarded a No-Cost Extension, your final scientific report is due when your project is completed.

In the case of certain partnerships, a progress report may be requested at the end of each funding year. Please follow the instructions included in your official grant offer.

The goal of this scientific report is to gather information about the projects that we are funding and evaluate their impact in terms of scientific output, publications, trainee formation and potential impact for cancer patients. The requested information will be used for the Cancer Research Society Impact Report that will be made available to our donors, partners and the scientific community.

In 2016, we changed our report format. You will find it online, look for the link in the Forms, reports and instructions section.

↑ Back to top







For any questions or support, contact:
grants@src-crs.ca, or 1 866 343-2262, ext. 234